16-66550053-C-CA
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_004614.5(TK2):c.8dupT(p.Trp4ValfsTer40) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_004614.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mitochondrial DNA depletion syndrome, myopathic formInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- autosomal recessive progressive external ophthalmoplegiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000540 AC: 1AN: 185134 AF XY: 0.00000988 show subpopulations
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Mitochondrial disease Pathogenic:1
TK2 p.Trp4ValfsTer40 (c.8dup) is a frameshift variant that results in the production of a truncated protein which is predicted to have a deleterious effect on TK2 gene function. It is also described as c.134dup and W42VfsX40 in the literature. This variant has been observed a proband affected with mitochondrial disease in the compound heterozygous state (PMID:22345218). This variant is not present at a significant frequency in gnomAD. In conclusion, we classify TK2 p.Trp4ValfsTer40 (c.8dup) as a pathogenic variant. -
Mitochondrial DNA depletion syndrome, myopathic form Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at